- Home
- DSGN vs SMBK Comparison
DSGN vs SMBK Comparison
Compare DSGN & SMBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DSGN | SMBK |
|---|---|---|
| Founded | 2017 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 819.6M | 698.6M |
| IPO Year | 2021 | 2000 |
Fundamental Metrics
Financial Performance| Metric | DSGN | SMBK |
|---|---|---|
| Price | $13.33 | $42.62 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | $15.25 | ★ $43.17 |
| AVG Volume (30 Days) | ★ 482.3K | 48.4K |
| Earning Date | 04-28-2026 | 04-20-2026 |
| Dividend Yield | N/A | ★ 0.77% |
| EPS Growth | N/A | ★ 39.25 |
| EPS | N/A | ★ 2.98 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $17.59 |
| Revenue Next Year | N/A | $10.30 |
| P/E Ratio | ★ N/A | $14.28 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.11 | $29.78 |
| 52 Week High | $17.25 | $43.91 |
Technical Indicators
Market Signals| Indicator | DSGN | SMBK |
|---|---|---|
| Relative Strength Index (RSI) | 55.22 | 58.92 |
| Support Level | $9.71 | $40.73 |
| Resistance Level | $13.54 | $43.31 |
| Average True Range (ATR) | 1.07 | 1.22 |
| MACD | 0.02 | -0.03 |
| Stochastic Oscillator | 25.42 | 63.54 |
Price Performance
Historical ComparisonAbout DSGN Design Therapeutics Inc.
Design Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the research and development of GeneTAC molecules, which are a novel class of small-molecule gene targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. Its pipeline includes Friedreich Ataxia, FECD, DM1, and Huntington's Disease. The company operates in one operating and reportable segment focused on utilizing the company's proprietary GeneTAC platform to design and develop therapeutic candidates for inherited diseases driven by nucleotide repeat expansion.
About SMBK SmartFinancial Inc.
SmartFinancial Inc operates as a bank holding company for SmartBank. It offers various banking and financial services to individuals and corporate customers. The principal business of the Bank consists of attracting deposits from the general public and investing those funds, together with funds generated from operations and from principal and interest payments on loans, mainly in commercial loans, commercial and residential real estate loans, consumer loans, and residential and commercial construction loans. The primary source of revenue is interest income from earning assets, namely loans and securities.